Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Remsima
Asia
Takeda, Moderna and more—Fierce Pharma Asia
Takeda halted narcolepsy trials. It also signed a gene therapy pact and worked with Moderna to identify the source of COVID vaccine impurities.
Angus Liu
Oct 8, 2021 10:00am
Celltrion makes case for Remicade biobetter with switch data
Oct 4, 2021 10:20am
Celltrion biosim stacks up to Roche's Herceptin in phase 3 trial
Jun 4, 2017 7:30am
Celltrion boosts case for Remicade biosim with real-world switch study
Oct 20, 2016 8:05am
